Skip to main content
Premium Trial:

Request an Annual Quote

US Food and Drug Administration, PerkinElmer

Premium

The US Food and Drug Administration has approved as a 510(k) PerkinElmer’s NeoGram Amino Acids and Acylcarnitines Tandem Mass Spectrometry Kit, which will be used to screen newborns for certain metabolic disorders. The test can screen “more than 40” disease markers with one sample, PerkinElmer said.

Filed under

The Scan

Renewed Gain-of-Function Worries

The New York Times writes that the pandemic is renewing concerns about gain-of-function research.

Who's Getting the Patents?

A trio of researchers has analyzed gender trends in biomedical patents issued between 1976 and 2010 in the US, New Scientist reports.

Other Uses

CBS Sunday Morning looks at how mRNA vaccine technology could be applied beyond SARS-CoV-2.

PLOS Papers Present Analysis of Cervicovaginal Microbiome, Glycosylation in Model Archaea, More

In PLOS this week: functional potential of the cervicovaginal microbiome, glycosylation patterns in model archaea, and more.